Low-end detection of Anti-Müllerian hormone

14 Nov 2019

Low-end detection of AMH is important in many research applications. In this application note learn how the picoAMH ELISA from AnshLabs is perfectly suited for the measurement of declining levels of AMH in studies of gonadotoxicity, oncofertility, primary ovarian insufficiency, premature ovarian aging and menopause.

MenoCheck picoAMH ELISA

Ansh Labs

The MenoCheck® picoAMH ELISA is FDA cleared for in vitro diagnostic use as an aid in the determination of menopausal status in women between 42 and 62 years of age. This is the only AMH test with the sensitivity to quantify declining AMH concentrations in women who are entering their menopausal transition.

(2)

Links

Tags

Low-end detection of Anti-Müllerian hormone